Effect of Fresh Frozen Plasma Transfusion on Electrochemical Parameters of Blood Plasma in Patients with Severe Combined Trauma

Purpose: to study the dynamics of blood plasma electrochemical parameters in patients with severe combined trauma before and after fresh frozen plasma (FFP) transfusions.

Materials and methods. The open circuit potential (OCP) of platinum electrode and antioxidant activity of blood plasma were studied in 35 patients with severe combined trauma and 35 post-FFP samples with at least 6-month shelf life. The electrochemical parameters of patients’ blood plasma were analyzed before transfusion, and 1 hr. and 24 hrs. after transfusion.

Results. OCP measured in FFP was found to be more positive vs. OCP measured in recipients' blood plasma in 34 out of 35 cases (97%). It has been shown that in patients with severe combined trauma, OCP increased from 5.047 [-7.553; 12.976] mV to 12.827 [-1.372; 24.764] mV and antioxidant activity decreased 24 hours after FFP transfusion from 16.979 [11.302; 20.946] µC to 13.551 [9.288; 18.405] µC. After FFP transfusion, there were no significant changes in clinical blood parameters.

Conclusion. By measuring electrochemical parameters of blood plasma in patients with severe combined trauma before and after FFP transfusions, it was discovered that in spite of absence of changes in blood parameters by routine methods, there are changes in the condition of the antioxidant system of the body, which manifest in the bias of patients’ blood plasma OCP towards higher positive values and decreased antioxidant activity. Redox imbalance in the body might cause the oxidative stress development.

1. Stanworth S.J.,Walsh T.S., Prescott R.J., Lee R.J.,Watson D.M.,Wyncoll, D., Intensive Care Study of Coagulopathy (ISOC) investigators. A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit. Care. 2011; 15 (2): R108. DOI: 10.1186/cc10129. PMID: 21466676

2. Norfolk D. (eds.). Handbook of Tranfusion Medicine. United Kingdom Blood Services. Norwich: TSO information & publishing solutions; 2013: 184. ISBN 978-0117068469.

3. Vincent J.L., Piagnerelli M. Transfusion in the intensive care unit. Crit. Care Med. 2006; 34 (5 Suppl): S96–S101. DOI: 10.1097/01.CCM. 0000214314.57109.CD. PMID: 16617264.

4. Khubutiya M.Sh., Shabanov A.K. The main causes of mortality in patients with severe concomitant trauma in the intensive care unit. Skoraya meditsinskaya pomoshch. 2010; 11 (3): 64–69 [In Russ.].

5. Bhananker S.M., Ramaiah R. Trends in trauma transfusion. Int. J. Crit. Illn. Inj. Sci. 2011; 1 (1): 51–56. DOI: 10.4103/2229-5151.79282. PMID: 22096774.

6. Prakash D. Anemia in the ICU: anemia of chronic disease versus anemia of acute illness. Crit. Care Clin. 2012; 28 (3): 333–343. DOI: 10.1016/j.ccc.2012.04.012. PMID: 22713609.

7. Thomas J., Jensen L., Nahirniak S., Gibney R.T.N. Anemia and blood transfusion practices in the critically ill: A prospective cohort review. Heart Lung. 2010; 39 (3): 217–225. DOI: 10.1016/j.hrtlng.2009.07.002. PMID: 20457342.

8. Davenport R.A., Brohi K. Cause of trauma-induced coagulopathy. Curr. Opin. Anaesthesiol. 2016; 29 (2): 212–219. DOI: 10.1097/ACO. 0000000000000295. PMID: 26705132.

9. Jovenko I.A., Kobelyackij Yu.Yu., Tsarev A.V., Kuzmova E.A., Klimenko K.A., Dubovskaya L.L., Selezneva U.V. Intensive therapy of blood loss, coagulopathy and hypovolemic shock in polytrauma. Meditsina neotlozhnyh sostoyanij. 2016; 4 (75): 64–71 [In Russ.]. DOI: 10.22141/2224-0586.4.75.2016.75819.

10. Protopopova E.B., Madzaev S.R., Sultanbaev U.S., Zarubin M.V., Fajbushevich A.G., Zhiburt E.B. New in evidence-based erythrocyte transfusion. Vestnik Natsionalnogo mediko-khirurgicheskogo centra im. N.I. Pirogova. 2015; 10 (1): 56–58 [In Russ.].

11. Chikaev V.F., Vdovin V.A., Galyautdinov F.SH., Ibragimov R.A. The features of infusion-transfusion therapy in the complex treatment of patients with combined trauma. Kazanskij meditsinskij zhurnal. 2015; 96 (3): 448–451 [In Russ.]. DOI: 1017750/KMJ2015-448.

12. Order of the Ministry of Health of the Russian Federation (Ministry of Health of Russia) of April 2, 2013 N 183n, Moscow «On the approval of the rules for the clinical use of donor blood and (or) its components.» Rossijskaya gazeta — Federalnyj vypusk. 2013; 190 (6166) [In Russ.]

13. Donor blood and its components. Guidelines for the use of donor blood components. GOST R 53470-2009. M.: Standartinform. 2010: 71. [In Russ.]

14. Spahn D.R., Bouillon B., Cerny V., Duranteau J., Filipescu D., Hunt B.J., Komadina R., Maegele M., Nardi G., Riddez L., Samama C-M.,Vincent J-L., Rossaint R. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit. Care. 2019; 23 (1): 98. DOI: 10.1186/s13054-019-2347-3. PMID: 30917843.

15. Decree of the Government of the Russian Federation of January 26, 2010 N 29 «On the approval of technical regulations on the safety requirements of blood, its products, blood substitute solutions and technical means used in transfusion-infusion therapy» URL: https://base.garant.ru/ [ Date of treatment April 16, 2020] [In Russ.]

16. Decree of the Government of the Russian Federation of June 22, 2019 N 797 «On approval of the Rules for the procurement, storage, transportation and clinical use of donor blood and its components and on the recognition as invalid of some acts of the Government of the Russian Federation.» URL: https: //base.garant.ru/72284110/ [Retrieved April 16, 2020] [In Russ.]

17. Guide to the preparation, use and quality assurance of blood components. European Directorate for the Quality of Medicines & HealthCare of the Council of Europe (EDQM). Strasbourg: EDQM Publishers; 2017: 540. ISBN 978-92-871-8415-3.

18. Green L., Bolton-Maggs P., Beattie C., Cardigan R., Kallis Y., Stanworth S.J., Thachil J., Zahra S. British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding. Br. J. Haematol. 2018; 181 (1): 54–67. DOI: 10.1111/bjh.15167. PMID: 29527654.

19. Akselrod B. A., Balashova E. N., Bautin A. E., Bahovadinov B. B., Biryukova L. S., Bulanov A. B., Fast O. A., Vinogradova M. A., Galstyan G. M., Gaponova T. V., Golovkina L. L., Gorokhovsky V. S., Eremenko A. A., Zhiburt E. B., Zhuravel S.V., Kohno A.V., Kuzmina L. A., Kulabukhov V.V., Kupriashov A. A., Lubnin A.Yu., Mazurok V. A., Menshugin I. N., Mineeva N. V., Mikhailova E. A., Nikitin E. A., Olovnikova N. I., Oshorov A.V., Pevtsov D. E., Poptsov V. N., Rogachevsky O.V., Salimov E. L., Titkov K.V., Trakhtman P. E., Troitskaya V.V., Fedorova T. A., Fidarova Z. T., Tsvetaeva N. V., Zhao A.V., Shestakov E. F. Clinical use of erythrocyte-containing components of donor blood. Gematologiya i transfuziologiya. 2018; 63 (4): 372–435 [In Russ.]. DOI: 10.25837/HAT.2019.62.39.006.

20. Manual on the management, maintenance and use of blood cold chain equipment. Geneva: World Health Organization; 2005: 92. ISBN 9241546735.

21. Wang D., Sun J., Solomon S.B., Klein H.G., Natanson C. Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion. 2012; 52 (6): 1184–1195. DOI: 10.1111/j.1537-2995.2011.03466.x. PMID: 22188419.

22. Bhaduri B., Kandel M., Brugnara C., Tangella K., Popescu G. Optical assay of erythrocyte function in banked blood. Sci. Rep. 2014; 4: 6211. DOI: 10.1038/srep06211. PMID: 25189281.

23. Koch C.G., Figueroa P.I., Li L., Sabik J.F. III, Mihaljevic T., Blackstone E.H. Red blood cell storage: how long is too long? Ann. Thorac. Surg. 2013; 96 (5): 1894–1899. DOI: 10.1016/j.athoracsur.2013.05.116. PMID: 24090578.

24. Henkelman S., Noorman F., Badloe J.F., Lagerberg, J.W. Utilization and quality of cryopreserved red blood cells in transfusion medicine. Vox Sang. 2015; 108 (2): 103–112. DOI: 10.1111/vox.12218. PMID: 25471135.

25. Chang A.L., Hoehn R.S., Jernigan P., Cox D., Schreiber M., Pritts T.A. Previous cryopreservation alters the natural history of the red blood cell storage lesion. Shock. 2016; 46 (3 Suppl 1): 89–95. DOI: 10.1097/SHK.0000000000000668. PMID: 27380532.

26. Berkovskij A.L.,Vatagina E.A., Sergeeva E.V., Suvorov A.V., Aleksanyan M.Zh. On the issue of the quality of fresh frozen plasma. Gematologiya i transfuziologiya. 2012; 57 (4): 32–34. [In Russ.]

27. Ragimov A.A., Shcherbakova G.N. Infusion-transfusion therapy. M: GEOTAR-Media; 2017: 256. ISBN 978-5-9704-4020-9.

28. Acker J.P., Marks D.C., Sheffield W.P. Quality Assessment of Established and Emerging Blood Components for Transfusion. J. Blood Transfus. 2016; 2016: 4860284. DOI: 10.1155/2016/4860284. PMID: 28070448.

29. Hess J.R. Red cell changes during storage. Transfus. Apher. Sci. 2010; 43 (1): 51–59. DOI: 10.1016/j.transci.2010.05.009. PMID: 20558107.

30. Kirkpatrick U.J., Adams R.A., Lardi A., McCollum C.N. Rheological properties and function of blood cells in stored bank blood and salvaged blood. Br. J. Haematol. 1998; 101 (2): 364–368. DOI: 10.1046/j.1365-2141.1998.00689.x. PMID: 9609536.

31. Luten M., Roerdinkholder-Stoelwinder B., Schaap N.P., De Grip W.J., Bos H.J., Bosman G.J. Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods. Transfusion. 2008; 48 (7): 1478–1485. DOI: 10.1111/j.15372995.2008.01734.x. PMID: 18482180.

32. Manchenko E.A., Kozlova E.K., Sergunova V.A., Chernysh A.M. Homogeneous Deformation of Native Erythrocytes During Long-Term Storage. General Reanimatology. 2019; 15 (5): 4–10. DOI: 10.15360/1813-9779-2019-5-4-10.

33. Illert W.E., Butsch H., Nuber D., Howe J., Sänger W.,Weidinger S. LongTerm Storage of Fresh Frozen Plasma at –40° C. A Multicenter Study on the Stability of Labile Coagulation Factors over a Period of 3 Years. Transf. Med. Hemoth. 2001; 28 (4): 189–194. DOI: 10.1159/000050236.

34. Goroncharovskaya I.V., Khvatov V.B., Evseev A.K., Shabanov A.K., Goldin M.M., Petrikov S.S. Monitoring of the Blood Plasma Redox Potential During Plasma Quarantining (Preliminary Report). General Reanimatology. 2019; 15 (1): 47–53. DOI: 10.15360/1813-9779-2019-1-47-53.

35. Kriebardis A.G., Antonelou M.H., Georgatzakou H.T., Tzounakas V.L., Stamoulis K.E., Papassideri I.S. Microparticles variability in fresh frozen plasma: preparation protocol and storage time effects. Blood Transfus. 2016; 14 (2): 228–237. DOI: 10.2450/2016.0179-15. PMID: 27136430.

36. Stratford N. Antioxidant potential of iv fluids. Br. J. Anaesth. 1997; 78 (6): 757–759. DOI: 10.1093/bja/78.6.757. PMID: 9215032.

37. Chevion S., Roberts M.A., Chevion M. The use of cyclic voltammetry for the evaluation of antioxidant capacity. Free Radic. Biol. Med. 2000; 28 (6): 860–870. DOI: 10.1016/s0891-5849(00)00178-7. PMID: 10802216.

38. Psotova J.,Zahalkova J., Hrbac J., Simanek V., Bartek J. Determination of total antioxidant capacity in plasma by cyclic voltammetry. Two case reports. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech. Repub. 2001; 145 (2): 81–83. PMID: 12426779

39. Tsivadze A.Yu., Petrikov S.S., Goroncharovskaya I.V., Evseev A.K., Shabanov A.K., Batishchev O.V., Andreev V.N., Goldin M.M. Voltammetric Analysis in Blood Serum in Patients with Severe Combined Trauma. Dokl. Phys. Chem. 2019; 486 (1): 67–69. DOI: 10.1134/S0012501619050014.

40. Khubutiya M.Sh., Evseev A. K., Kolesnikov V.A., Goldin M.M., Davydov A.D.,Volkov A.G., Stepanov A.A. Measurements of Platinum Electrode Potential in Blood and Blood Plasma and Serum. Russ. J. Electrochem. 2010; 46 (5): 537–541. DOI: 10.1134/S1023193510050071.

41. Goldin Michael M., Khubutia M.Sh., Evseev A.K., Goldin Mark M., Pinchuk A.V., Pervakova E.I., Tarabrin Y.A., Hall P.J. Noninvasive Diagnosis of Dysfunctions in Patients After Organ Transplantation by Monitoring the Redox Potential of Blood Serum. Transplantation. 2015; 99 (6): 1288–1292. DOI: 10.1097/tp.0000000000000519. PMID: 25606793.

42. Holland L.L., Brooks J.P. Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am. J. Clin. Pathol. 2006; 126 (1): 133–139. DOI: 10.1309/NQXHUG7H-ND78-LFFK. PMID: 16753596.

43. Shinagare S.A., Angarkar N.N., Desai S.R., Naniwadekar M.R. An audit of fresh frozen plasma usage and effect of fresh frozen plasma on the pre–transfusion international normalized ratio. Asian J. Transfus. Sci. 2010; 4 (2): 128–132. DOI: 10.4103/0973-6247.67024. PMID: 20859514.

44. Shikdar S., Agrawal K., Ghionni N., Hommadov K., Abdollahi S., Micaily I., Green E. The Appropriateness of Fresh Frozen Plasma (FFP) Administration in Three Community Teaching Hospitals. Blood. 2019; 134 (Suppl. 1): 5789. DOI: 10.1182/blood-2019-127693.

45. Abdel-Wahab O.I., Healy B., Dzik W.H. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion. 2006; 46 (8): 1279–1285. DOI: 10.1111/j.1537-2995.2006.00891.x. PMID: 16934060.

46. Sezik S., Aksay E., Kýlýç T.Y. The effect of fresh frozen plasma transfusion on international normalized ratio in emergency department patients. J. Emerg. Med. 2014; 47 (5): 596–600. DOI: 10.1016/j.jemermed. 2014.04.042. PMID: 25074780.